7 days ago - Biogen is latest with a gene-therapy buy. Biogen says it will acquire UK-based Nightstar Therapeutics for $800 million, a 68% premium ove...
7 days ago - Biogen is latest with a gene-therapy buy. Biogen says it will acquire UK-based Nightstar Therapeutics for $800 million, a 68% premium over the ...
